Article
Comparison of Aptima and hybrid capture-2 HPV tests and Pap test in the referral population in Japan.
Journal of medical virology - 1 Aug 2021
Kuroki Hiroko, Sakamoto Jinichi, Shibata Takeo, Takakura Masahiro, Sasagawa Toshiyuki
Abstract excerpt
The Aptima human papillomavirus (HPV) test (APTIMA) detects E6-E7 mRNA in abnormal cells in the uterine cervix. To investigate the accuracy of APTIMA for cervical cancer screening in Japan, 423 subjects, mostly referrals with abnormal cytology or being followed up for cervical intraepithelial neoplasia (CIN)1, were screened using two HPV tests, hybrid capture 2 (HC2) and APTIMA, and by the Pap test. Colposcopy...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
